NASDAQ:GRCE | Free Cash Flow | Grace Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2019-06-30 to 2026-06-30
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-06-30-$3.22M
2026-03-31-$1.7M
2025-06-30-$1.8M
2025-03-31-$2.95M
2024-06-30-$3.6M
2024-03-31-$2.09M
2023-06-30-$6.24M
2023-03-31-$3.33M
2022-06-30-$5.43M
2022-03-31-$3.15M
2021-12-31-$4.58M
2021-09-30-$6.1M
2021-06-30-$3.4M
2021-03-31-$1.76M
2020-12-31-$4.21M
2020-09-30-$4.18M
2020-06-30-$4.17M$36,000.00-$4.21M
2020-03-31-$2.9M
2019-12-31-$7.1M
2019-09-30-$6.15M
2019-06-30-$6.82M$19,000.00-$6.84M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$8.87M
2025-03-31-$14.9M
2024-03-31-$12.33M
2023-03-31-$15.91M
2022-03-31-$17.23M
2021-03-31-$14.32M
2020-03-31-$22.95M